Research indicates that recurrent mutant genes in pancreatic cancer are predominantly enriched in signaling pathways such as KRAS, TGF‐β, WNT, and NOTCH, which is consistent with our findings [37]. The gene discussed is KRAS; the disease is familial pancreatic carcinoma.